BESSEMER GROUP INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 193 filers reported holding HAEMONETICS CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$46
+1433.3%
552
+1391.9%
0.00%
Q1 2024$3
-25.0%
37
-19.6%
0.00%
Q4 2023$4
-50.0%
46
-47.7%
0.00%
Q3 2023$8
+100.0%
88
+109.5%
0.00%
Q2 2023$4420.00%
Q4 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2020$4,012,000
-10.1%
44,8000.0%0.01%
-27.8%
Q1 2020$4,465,000
-9.8%
44,800
+3.9%
0.02%
+12.5%
Q4 2019$4,952,000
-8.3%
43,100
+0.7%
0.02%
-15.8%
Q3 2019$5,399,000
+7.1%
42,800
+2.1%
0.02%
+11.8%
Q2 2019$5,042,000
+65.1%
41,900
+20.1%
0.02%
+41.7%
Q1 2019$3,053,000
-10.0%
34,900
+2.9%
0.01%
-20.0%
Q4 2018$3,392,000
+5.0%
33,900
+20.2%
0.02%
+25.0%
Q3 2018$3,231,000
+25.1%
28,200
-2.1%
0.01%
+20.0%
Q2 2018$2,583,000
+12.8%
28,800
-8.0%
0.01%
+11.1%
Q1 2018$2,290,000
+3.8%
31,300
-17.6%
0.01%0.0%
Q4 2017$2,207,000
-16.2%
38,000
-35.3%
0.01%
-18.2%
Q3 2017$2,634,000
+15.0%
58,700
+1.2%
0.01%
+22.2%
Q2 2017$2,290,000
-2.0%
58,000
+0.7%
0.01%
-10.0%
Q1 2017$2,337,000
+0.9%
57,6000.0%0.01%
-9.1%
Q4 2016$2,316,000
+16.9%
57,600
+5.3%
0.01%
+10.0%
Q3 2016$1,981,000
+98950.0%
54,700
+118813.0%
0.01%
Q1 2016$2,000
+100.0%
46
+17.9%
0.00%
Q2 2014$1,000
-75.0%
39
-57.6%
0.00%
Q4 2013$4,000920.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders